18 results
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
% BLA to approval and (iii) 64% cumulative POS.
AMTI-Prepared Projections (unadjusted)
(In millions)
Revenue
Cogs
R&D
S&M
G&A
D&A
EBIT
AMTI … -Prepared Projections (adjusted)
(In millions)
Revenue
Cogs
R&D
S&M
G&A
D&A
EBIT
Tax Expense
Change in NWC
ULFCF
Opinion of Financial Advisor to AMTI
8-K
EX-99.1
AMTI
Applied Molecular Transport Inc.
9 Nov 23
Applied Molecular Transport Reports Third Quarter 2023 Financial Results
4:04pm
data and preparation for NDA submission
Financial Results for the Third Quarter Ended September 30, 2023
Research and development (R&D) expenses. Total … R&D expenses for the third quarter of 2023 were $0.3 million, compared to $18.2 million for the same period in 2022. The overall decrease
8-K
EX-99.1
AMTI
Applied Molecular Transport Inc.
14 Aug 23
Applied Molecular Transport Reports Second Quarter 2023 Financial Results
4:06pm
30, 2023.
Financial Results for the Second Quarter Ended June 30, 2023
Research and development (R&D) expenses. Total R&D expenses for the second
8-K
EX-99.1
AMTI
Applied Molecular Transport Inc.
11 May 23
Applied Molecular Transport Reports First Quarter 2023 Financial Results
4:09pm
as a consultant
Financial Results for the First Quarter Ended March 31, 2023
Research and development (R&D) expenses. Total R&D expenses
8-K
EX-99.1
AMTI
Applied Molecular Transport Inc.
7 Nov 22
Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:07pm
Financial Results for the Third Quarter Ended September 30, 2022
Research and development (R&D) expenses. Total R&D expenses for the third quarter
8-K
EX-99.1
9jpn048gba6do0jrao
4 Aug 22
Applied Molecular Transport Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
l16ipkgu 75
9 May 22
Applied Molecular Transport Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:07pm
10-K/A
3awsw
25 Mar 22
Annual report (amended)
8:20am
8-K
EX-99.1
wfzos3xueum1
24 Feb 22
Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:06pm
8-K
EX-99.1
a4aw7mt6z 47gu2
10 Nov 21
Applied Molecular Transport Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
j1iempk 4v
10 Aug 21
Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
ip2 9moc1zf
13 May 21
Applied Molecular Transport Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
xnqn u75l04fjsu6oz
19 Mar 21
Applied Molecular Transport Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
q05 vx4sv2w9
12 Nov 20
Applied Molecular Transport Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:06pm
8-K
EX-99.1
d7fxsvf 5ei
11 Aug 20
Applied Molecular Transport Reports Second Quarter 2020 Financial Results
4:17pm
CORRESP
db37rmntyvt
20 May 20
Correspondence with SEC
12:00am
- Prev
- 1
- Next